1 Friendship Road, Yuzhong District Chongqing
Chongqing, China
NCT Number: NCT06871956
Background:Management of clinically node-negative(cN0) papillary thyroid microcarcinoma (PTMC) is complicated by high occult lymph node metastasis (LNM) rates. We aimed to develop and validate a prediction model for central LNM using machine learning (ML) and traditional nomograms through Probability-based Ranking Model Approach (PMRA).
Methods: We conducted a prospective multicenter study involving 4,882 patients across 3 hospitals (2016-2023). After applying inclusion criteria, 1,953 patients from the primary center were allocated to model train and test (7:3 ratio). External validation included prospective cohorts of 286 and 176 patients from two independent centers.13 ML algorithms and traditional nomogram models were systematically evaluated using PMRA.We compared models using preoperative features alone versus those incorporating both preoperative and intraoperative frozen section pathology data. Feature selection utilized six methods, with L1-based selection proving optimal for most predictions.Model interpretability was enhanced through SHapley Additive exPlanations (SHAP) visualization.
Looking for future studies?
Notify MeAll sexes
Observational
Chongqing, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
PMRA and Shapley-Based Machine Learning for Predicting Lymph Node Metastasis in Central Subregions of Clinically Node-Negative Papillary Thyroid Microcarcinoma: A Prospective Multicenter Validation and Development of a Web Calculator
Time frame: 2016-2023
First Affiliated Hospital of Chongqing Medical University
Other
Acronym: PMRA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07506161
Papillary Thyroid Microcarcinoma
Budapest, Hungary
View Trial DetailsNCT07107503
Long-term Outcomes, Papillary Thyroid Microcarcinoma
View Trial DetailsNCT04129411
Adenocarcinoma, Adenocarcinoma, Papillary
Rochester, Minnesota, United States
View Trial DetailsNCT06583057
Endocrine Gland Neoplasms, Endocrine System Diseases
Beijing, Beijing Municipality, China
View Trial Details